Ravelcare Limited has submitted a regulatory disclosure to BSE Limited regarding an upcoming board meeting. The Meeting of the Board of Directors will be held on Thursday, November 12, 2026. The primary agenda item is to consider and approve the Unaudited Financial Results for the half year ended on September 30, 2026.
The company had previously intimated on September 26, 2026 that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window of the Company has been closed from October 01, 2026. The trading window will remain closed until 48 hours after the declaration of the Financial Results for the half year ended September 30, 2026.
The disclosure is signed by Alpesh Rajesh Bhatt, Company Secretary and Compliance Officer of Ravelcare Limited, and is addressed to BSE Limited at Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001.
Financial Impact
Financial results for the period have not been declared yet. The impact will be determined following board approval on November 12, 2026.